Literature DB >> 18986758

Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG.

Shiroh Miura1, Hiroko Nakagawara, Hayato Kaida, Minoru Sugita, Kazuhito Noda, Kyoko Motomura, Yasumasa Ohyagi, Mitsuyoshi Ayabe, Hisamichi Aizawa, Masatoshi Ishibashi, Takayuki Taniwaki.   

Abstract

Two cases of spinocerebellar ataxia type 14 (SCA14) with a G128D mutation in the protein kinase C gamma gene (PRKCG) without a definite family history have been reported previously. Here, we describe the first familial cases of SCA14 with a G128D mutation in PRKCG. Among three family members, the chief complaints varied and included ataxic gait, cervical dystonia, and positional vertigo. Moreover, retinal degeneration and facial muscle weakness were observed, although these are not expected to be present in SCA14. Cerebral blood flow evaluation using single photon emission computed tomography (SPECT) also differed among family members. It is possible that patients with the G128D mutation suffering from SCA14 may sometimes be classified as unaffected due to the varying clinical signs among family members.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18986758     DOI: 10.1016/j.clineuro.2008.09.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  10 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

2.  A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult.

Authors:  Katherine E Hekman; Guo-Yun Yu; Christopher D Brown; Haipeng Zhu; Xiaofei Du; Kristina Gervin; Dag Erik Undlien; April Peterson; Giovanni Stevanin; H Brent Clark; Stefan M Pulst; Thomas D Bird; Kevin P White; Christopher M Gomez
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

Review 3.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

4.  Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse.

Authors:  Yunong Zhang; Adam Snider; Lloyd Willard; Dolores J Takemoto; Dingbo Lin
Journal:  Biochem Biophys Res Commun       Date:  2008-12-03       Impact factor: 3.575

5.  Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14.

Authors:  Christos Ganos; Simone Zittel; Martina Minnerop; Odette Schunke; Christina Heinbokel; Christian Gerloff; Christine Zühlke; Peter Bauer; Thomas Klockgether; Alexander Münchau; Tobias Bäumer
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 6.  Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics.

Authors:  Nathaniel Robb Whaley; Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  Orphanet J Rare Dis       Date:  2011-05-28       Impact factor: 4.123

7.  Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders.

Authors:  Maria A Briscione; Ashok R Dinasarapu; Pritha Bagchi; Yuping Donsante; Kaitlyn M Roman; Anthony M Downs; Xueliang Fan; Jessica Hoehner; H A Jinnah; Ellen J Hess
Journal:  Mol Genet Metab       Date:  2021-06-02       Impact factor: 4.204

8.  Cognition is only minimally impaired in Spinocerebellar ataxia type 14 (SCA14): a neuropsychological study of ten Norwegian subjects compared to intrafamilial controls and population norm.

Authors:  Iselin Marie Wedding; Jeanette Koht; Espen Dietrichs; Nils Inge Landrø; Chantal M E Tallaksen
Journal:  BMC Neurol       Date:  2013-11-29       Impact factor: 2.474

9.  Investigation of Visual System Involvement in Spinocerebellar Ataxia Type 14.

Authors:  Thomas Ihl; Ella M Kadas; Timm Oberwahrenbrock; Matthias Endres; Thomas Klockgether; Jan Schroeter; Alexander U Brandt; Friedemann Paul; Martina Minnerop; Sarah Doss; Tanja Schmitz-Hübsch; Hanna G Zimmermann
Journal:  Cerebellum       Date:  2020-08       Impact factor: 3.847

Review 10.  Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.

Authors:  Sterre van der Veen; Rodi Zutt; Christine Klein; Connie Marras; Samuel F Berkovic; John N Caviness; Hiroshi Shibasaki; Tom J de Koning; Marina A J Tijssen
Journal:  Mov Disord       Date:  2019-10-04       Impact factor: 10.338

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.